Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5583389 | Journal of Critical Care | 2017 | 42 Pages |
Abstract
The optimal targets and strategies for anticoagulation in VA-ECMO are unclear. Evaluation of major bleeding and thromboembolic events is limited by study quality and between-study heterogeneity. Clinical trials are needed to investigate the optimal anticoagulation strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Eric MD, Michael C. MD, Laurence MD, Eddy MD, PhD, Hussein D. MD, MSc, MPH,